Navigation Links
Neogen Named to Fortune's List of 40 Stocks 'To Retire On'

LANSING, Mich., June 18 /PRNewswire-FirstCall/ -- Fortune Magazine has named Neogen Corporation (Nasdaq: NEOG) as a selection in its annual list of the "40 best stocks to retire on."

Fortune first launched its Fortune 40 list in 2002, stating: "We wanted to assemble a diversified, dependable portfolio of stocks for the long term - a selection that could soar when the market did but also hold steady during darker times."

"We are pleased any time we receive independent recognition of Neogen's outstanding performance, and especially when it comes from a source as trusted as Fortune," said James Herbert, Neogen's CEO. "In our opinion, this list represents a valuable source of information for the investment community to help identify companies that are succeeding in a very difficult economic environment."

In making its selection, Fortune said: "Newcomers include biotech Neogen (NEOG), which sells an array of products focused on food safety from farm to factory, including test kits that help foodmakers detect allergens, toxins, and bacteria like E. coli. This business should benefit from increased regulation and growing consumer concern about the food supply. The company, which boasts zero debt, posted its 64th consecutive profitable quarter in March."

"This is one of the few companies that has grown through this entire [economic] mess, and we think it gets easier for them to grow from here," Steven Crowley of Craig-Hallum Capital Group told Fortune. Crowley said he expects Neogen's revenues to grow 10% and earnings to increase by 13% over the next year.

Fortune said that its Fortune 40, which is updated annually, has averaged 10% annualized returns since its inception in 2002, nearly doubling the S&P's 5.1% over the same time period.

Sidoti & Company initiates research coverage of Neogen

Neogen's success has also led to increased research coverage of the company, with a sixth firm now providing analysis. New York-based Sidoti & Company ( has joined Hilliard Lyons, Roth Capital Partners, Stonegate Securities, Stephens Inc. Investment Bankers, and Craig-Hallum Capital Group in providing coverage of Neogen.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Partners With Chinese Government
2. Neogen Develops Quickest Single Test for Beta-Lactams and Tetracyclines in Milk
3. Neogen Reports Record Third Quarter
4. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
5. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
6. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
7. Neogen Names New Senior Science Officer; Added to S&P Index
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
10. Neogen Reports Best Quarter in Its 26-Year History
11. Neogen Announces New Share Repurchase Program
Post Your Comments:
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
(Date:11/24/2015)... LOS ANGELES , Nov. 24, 2015 ... a biotechnology company focused on the discovery, development and ... Marban , Ph.D., Chief Executive Officer, is scheduled to ... December 1, 2015 at 10:50 a.m. EST, at The ... York City . . ...
(Date:11/24/2015)... NEW YORK , November 24, 2015 ... in a European healthcare ... in which the companies will work closely together in identifying ... of unmet medical need. The collaboration is underpinned by a ... LSP fund. This is the first investment by Bristol-Myers Squibb ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... JOLLA, Calif. , Oct. 29, 2015  The ... a new report titled, "DNA Synthesis and Biosecurity: Lessons ... well the Department of Health and Human Services guidance ... issued in 2010. --> ... but it also has the potential to pose unique ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):